GR3021706T3 - Pharmaceutical formulation containing dirithromycin - Google Patents

Pharmaceutical formulation containing dirithromycin

Info

Publication number
GR3021706T3
GR3021706T3 GR960403099T GR960403099T GR3021706T3 GR 3021706 T3 GR3021706 T3 GR 3021706T3 GR 960403099 T GR960403099 T GR 960403099T GR 960403099 T GR960403099 T GR 960403099T GR 3021706 T3 GR3021706 T3 GR 3021706T3
Authority
GR
Greece
Prior art keywords
pharmaceutical formulation
formulation containing
dirithromycin
containing dirithromycin
tablet containing
Prior art date
Application number
GR960403099T
Other languages
Greek (el)
Inventor
James Michael Greene
Holly Marie Hankins
Gregory Alan Stephenson
David Dale Wirth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of GR3021706T3 publication Critical patent/GR3021706T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Formation And Processing Of Food Products (AREA)

Abstract

A tablet containing dirithromycin Form II.
GR960403099T 1991-04-29 1996-11-20 Pharmaceutical formulation containing dirithromycin GR3021706T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29

Publications (1)

Publication Number Publication Date
GR3021706T3 true GR3021706T3 (en) 1997-02-28

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
GR960401812T GR3020439T3 (en) 1991-04-29 1996-07-02 Pharmaceutical compounds
GR960403099T GR3021706T3 (en) 1991-04-29 1996-11-20 Pharmaceutical formulation containing dirithromycin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GR960401812T GR3020439T3 (en) 1991-04-29 1996-07-02 Pharmaceutical compounds

Country Status (27)

Country Link
EP (2) EP0511800B1 (en)
JP (2) JP3135672B2 (en)
KR (2) KR100193742B1 (en)
CN (2) CN1030611C (en)
AT (2) ATE138924T1 (en)
AU (2) AU655978B2 (en)
BR (2) BR9201540A (en)
CA (2) CA2067275C (en)
CY (2) CY1946A (en)
CZ (2) CZ282021B6 (en)
DE (2) DE69214710T2 (en)
DK (2) DK0511800T3 (en)
ES (2) ES2093779T3 (en)
FI (2) FI921876A (en)
GR (2) GR3020439T3 (en)
HK (2) HK153696A (en)
HU (2) HU213613B (en)
IE (2) IE74885B1 (en)
IL (2) IL101705A (en)
MX (2) MX9201946A (en)
MY (2) MY109498A (en)
NO (2) NO179504C (en)
NZ (2) NZ242505A (en)
RU (2) RU2070203C1 (en)
TW (2) TW216399B (en)
YU (2) YU44492A (en)
ZA (2) ZA922776B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (en) * 1992-07-30 1996-03-01 Pfizer
CR5278A (en) * 1995-03-24 1996-07-04 Lilly Co Eli ORAL FORMULATION OF 2-METHYL-THENO-BENZODIACEPINE
ES2173057T3 (en) * 1996-07-29 2004-11-16 Abbott Laboratories PREPARATION OF THE CLARITROMYCIN CRYSTALINE FORM II.
HUP9904065A3 (en) * 1996-09-24 2001-10-29 Lilly Co Eli Coated particle formulations containing olanzapine
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
CA2670482C (en) * 2006-12-05 2011-10-11 Pfizer Inc. Motilide polymorphs
CN102145008B (en) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 Dirithromycin medicinal composition and preparation method thereof
CN107151261B (en) * 2017-06-09 2020-06-12 广州大光制药有限公司 Crystal form of dirithromycin compound and crystal preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342770B (en) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K PROCESS FOR PRODUCING NEW ERYTHROMYCINE DERIVATIVES
DE2515075C2 (en) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycin derivatives, processes for their preparation and pharmaceuticals containing these compounds
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (en) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K SOLID PHARMACEUTICAL FORMS FOR PERORAL USE CONTAINING 9-DEOXO-11-DEOXY-9,11- (IMINO (2- (2-METHOXYETHOXY) ETHYLIDEN) -OXY) - (9S) -ERYTHROMYCIN AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
KR100193742B1 (en) 1999-06-15
FI921876A (en) 1992-10-30
HU9201398D0 (en) 1992-07-28
IE76296B1 (en) 1997-10-08
NO179504B (en) 1996-07-15
CN1066186A (en) 1992-11-18
CY1946A (en) 1992-04-27
DE69211220T2 (en) 1996-11-07
HK215096A (en) 1996-12-13
IL101705A0 (en) 1992-12-30
NZ242505A (en) 1993-06-25
YU44492A (en) 1994-06-24
ATE144425T1 (en) 1996-11-15
MX9201946A (en) 1992-11-01
ATE138924T1 (en) 1996-06-15
MY109498A (en) 1997-02-28
BR9201541A (en) 1992-12-01
CN1030611C (en) 1996-01-03
NO180450C (en) 1997-04-23
GR3020439T3 (en) 1996-10-31
KR100194307B1 (en) 1999-06-15
NO180450B (en) 1997-01-13
JPH05117154A (en) 1993-05-14
DK0511799T3 (en) 1996-06-24
NO921617L (en) 1992-10-30
CA2067275A1 (en) 1992-10-30
KR920019364A (en) 1992-11-19
JP3333545B2 (en) 2002-10-15
NO921616L (en) 1992-10-30
EP0511799A1 (en) 1992-11-04
TW216399B (en) 1993-11-21
EP0511800A1 (en) 1992-11-04
HU213613B (en) 1997-08-28
AU1525592A (en) 1992-11-05
BR9201540A (en) 1992-12-01
AU655978B2 (en) 1995-01-19
IL101705A (en) 1996-01-31
RU2045953C1 (en) 1995-10-20
FI921877A0 (en) 1992-04-27
FI921876A0 (en) 1992-04-27
EP0511800B1 (en) 1996-10-23
EP0511799B1 (en) 1996-06-05
AU1525792A (en) 1992-11-05
KR920019365A (en) 1992-11-19
CS127692A3 (en) 1992-11-18
HUT63956A (en) 1993-11-29
AU646734B2 (en) 1994-03-03
RU2070203C1 (en) 1996-12-10
IL101704A0 (en) 1992-12-30
MX9201944A (en) 1992-11-01
CZ282218B6 (en) 1997-06-11
NO921616D0 (en) 1992-04-27
CA2067274A1 (en) 1992-10-30
CN1066270A (en) 1992-11-18
CZ282021B6 (en) 1997-04-16
HK153696A (en) 1996-08-16
DE69211220D1 (en) 1996-07-11
ZA922777B (en) 1993-10-15
HU9203168D0 (en) 1992-12-28
TW315371B (en) 1997-09-11
ES2093779T3 (en) 1997-01-01
JPH05117289A (en) 1993-05-14
DK0511800T3 (en) 1997-04-21
HUT62595A (en) 1993-05-28
CS127792A3 (en) 1992-11-18
FI921877A (en) 1992-10-30
CN1069197C (en) 2001-08-08
ES2088098T3 (en) 1996-08-01
FI101795B (en) 1998-08-31
FI101795B1 (en) 1998-08-31
ZA922776B (en) 1993-10-15
HU215917B (en) 1999-03-29
IE921345A1 (en) 1992-11-04
IE74885B1 (en) 1997-08-13
IL101704A (en) 1998-02-22
DE69214710T2 (en) 1997-03-13
DE69214710D1 (en) 1996-11-28
CY1975A (en) 1997-09-05
NO921617D0 (en) 1992-04-27
NZ242506A (en) 1993-09-27
IE921346A1 (en) 1992-11-04
YU44392A (en) 1994-12-28
CA2067274C (en) 2002-10-15
MY114226A (en) 2002-09-30
NO179504C (en) 1996-10-23
JP3135672B2 (en) 2001-02-19
CA2067275C (en) 2002-11-26

Similar Documents

Publication Publication Date Title
GR3036937T3 (en) Pharmaceutical formulations.
ZA926020B (en) Pharmaceutical combination formulation.
IL101679A0 (en) Pharmaceutical tablet formulation
CY1975A (en) Pharmaceutical formulation containing dirithromycin
ZA927506B (en) New drug formulation.
ZA929825B (en) A pharmaceutical formulation.
GB9121304D0 (en) A novel pharmaceutical formulation
GB9112974D0 (en) Pharmaceutical formulation